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Abstract
Hemolysins are a class of proteins defined by their ability to lyse red cells but have been described 
to exhibit pleiotropic functions. These proteins have been extensively studied in bacteria and more 
recently in fungi. Within the last decade, a number of studies have characterized fungal 
hemolysins and revealed a fascinating yet diverse group of proteins. The purpose of this review is 
to provide a synopsis of the known fungal hemolysins with an emphasis on those belonging to the 
aegerolysin protein family. New insight and perspective into fungal hemolysins in biotechnology 




Hemolysins have been classically defined as exotoxins that are capable of lysing red blood 
cells as well as nucleated cells. Current knowledge suggests that hemolysins are pore-
forming toxins that interact with specific ligands on the surface of various target cells [1]. 
Although extensively studied in various bacterial species [1,2], hemolysins have also been 
reported in fungi [3,4], plants [5], invertebrates [6– 8], and mammals (perforins) [9]. 
Bacterial hemolysins have been well characterized due to the role of these proteins in 
pathogenesis and, their structural details, mechanisms of hemolysis, ligand differences on 
target cells, and diagnostic potential have been described [2,10– 19]. In contrast, less is 
known about fungal hemolysins. In this review, we aim to describe the structural and 
biochemical features and the pleiotropic functions of these fungal proteins, with emphasis on 
aegerolysins. Furthermore, we identify current issues with the isolation and characterization 
of these proteins and provide perspectives into the possible role for these proteins in fungal 
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biology, health, and biotechnology. In addition, we will discuss comparisons to bacterial 
hemolytic proteins that share sequence homology to fungal hemolysins.
Hemolysins were first reported in higher fungi in 1907 and 1911 by W. W. Ford while 
studying various basidiomycete genera including Amanita, Entoloma, Lactarius, and 
Inocybe [20,21]. In 1939, Henrici, a microbiologist at University of Minnesota in 
Minneapolis, reported the first hemolytic activity in filamentous fungi while investigating 
the pathogenic ascomycete species, Aspergillus fumigatus and Aspergillus flavus [22]. The 
authors reported that extracts collected from the mycelium of the fungus grown for 2 – 4 
days were heat sensitive, hemolytic, and produced necrosis and edema when introduced in 
experimental animals. Further studies by Salvin in 1951 at the Rocky Mountain Laboratory 
in Hamilton, Montana, led to the identification of similar hemolytic activity in the endemic 
fungal pathogens, Histoplasma capsulatum and Blastomyces dermatidis, as well as the 
opportunistic pathogens, including Candida albicans and Cryptococcus neoformans [23]. 
This was the first report that suggested the existence of more than one fungal hemolysin. To 
date, hemolysins have been identified and partially characterized from a wide variety of 
fungal species and these are summarized in Table 1.
During the last decade, the study of fungal hemolysins has benefitted from efforts to 
sequence the genomes of medically and biotechnologically important fungal species [24– 
29]. Using bioinformatic approaches, these databases have enabled investigators to identify 
homologous hemolytic proteins from other fungal species. One cluster of these proteins, 
including hemolytically active representatives has been identified as the Aegerolysin family 
(IPR009413, Pfam: PF06355; Table 1) [30], with Aa-Pri1 (aegerolysin) as the prototype. 
Aegerolysins form the largest group of fungal hemolysins that have been characterized. 
They are generally small in size (15 – 20 kDa) with a β-sheet structure, conserved cysteine 
residues, and characterized by a large number of aromatic and acidic residues. These 
proteins are stable over a wide range of pH but are heat labile above temperatures of 60 – 
65°C. Interestingly, aegerolysins have also been identified in plants such as Selaginella 
moellen-dorffi [31], insects like Chrysodeixis includens, and the dsDNA virus Trichoplusia 
ni ascovirus 2c [32,33].
However, proteins from other families have also been implicated in hemolysis. The genomic 
data derived from fungi has also aided in the identification of homologous proteins in 
bacterial species including Pseudomonas aeruginosa, Clostridium bifermentans, 
Burkholderia glumae, Vibrio cholerae as well as some others [34– 37].
Mechanism of hemolysis
Fungal hemolysins are typically found in a β-sheet conformation, barring the exception of 
nigerlysin [30,38– 40]. An in silico secondary structure analysis of protein sequences 
suggests that all the proteins belonging to the aegerolysin family are β -sheet proteins. The 
aegerolysins are pore-forming proteins that aggregate on the cell surface after recognition of 
distinct membrane components. The process of pore formation is dependent on protein 
conformation and unfolding as for all pore-forming toxins [1]. Experimentally, ostreolysin 
was found to bind in a β -sheet conformation and then unfold into an α-helical structure 
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following permeabilization of target vesicles [41]. Similarly, unfolding of ostreolysin from a 
β-sheet conformation to α -helical structure prior to interacting with target cells resulted in 
the loss of lytic activity [38]. These studies demonstrate that the β-sheet conformation is an 
important prerequisite for initial ligand recognition on target cells that results in eventual 
permeabilization.
Bacterial β -sheet hemolysins have been characterized as small β -pore forming toxins such 
as aerolysin ( Aeromonas hydrophila ) and α-toxins (Staphylococcus aureus and Clostridium 
septicum ), cholesterol dependent cytolysins (CDCs) such as streptolysin O ( Streptococcus 
pyogenes) and listeriolysin O ( Listeria monocytogenes ) or AB toxins such as the diphtheria 
toxin ( Corynebacterium diphtheriae ) [1]. Current knowledge of fungal hemolysin structure 
does not provide enough information for similar categorization. Fungal hemolysins such as 
ostreolysin have been reported to form pores 4 nm in size [41], slightly larger than that 
reported for aerolysin (2 nm) [42]. Elsewhere, in the two-component hemolysin system of 
Pleurotus ostreatus, pleurotolysin A and B form pores of 3.8 – 5 nm in size [43]. 
Flammutoxin has been reported to form pores of at least two different sizes [44]. 
Collectively, these sizes reported in these studies are smaller than those typically observed 
for other β-pore-forming toxins (15 – 30 nm) and CDCs (350 – 500 nm) [45].
Some fungal hemolysins from the aegerolysin family also appear to act like thiol-activated 
CDCs in terms of receptor specificities. Like many CDCs, ostreolysin has been reported to 
require interaction with cholesterol rich domains in the membrane [46]. However, 
ostreolysin cannot bind pure cholesterol and only interacts with cholesterol when it is in 
association with sphingomyelin. These observations are similar to those made for the 
bacterial cytolysin of Vibrio cholerae [47].
The two component hemolysin system of pleurotolysin A and B in P. ostreatus appears to 
have involvement of the A and B components, but do not behave like the AB toxins in 
bacteria [43]. It appears that unlike the B subunit of the AB toxin in bacteria, which does not 
insert in the membrane of target cells, both pleurotolysin components appear to bind to the 
membrane directly. Based on these experimental findings, fungal hemolysins likely 
represent a novel class of β-sheet pore-forming toxins that form pores closer to the size of 
small β-pore-forming toxins but rely on interactions with cholesterol rich domains like 
CDCs.
Lectin-based hemolytic activity has also been reported in the parasitic basidiomycete, 
Laetiporus sulphureus [48]. This hemolysin has structural similarities to α toxin from 
Clostridium septicum and the mosquitocidal toxin (MTX2) derived from Bacillus sphaericus 
[49]. The hemolytic protein designated as LSL (Laetiporus sulphureus lectin) is composed 
of two domains with different functions. The N-terminal domain recognizes carbohydrate 
epitopes, while the C-terminal domain is required for oligomerization. Interestingly, the C-
terminal domain is very similar in structure to aerolysin (A. hydrophila) [50] and the 
removal of this domain in mutagenesis studies completely removed hemolytic activity. 
These findings are consistent with the principle that oligomerization on the surface of target 
cells is an essential step prior to pore formation. More detailed information on LSL can be 
found elsewhere [51].
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Very few studies have examined the kinetics of fungal hemolysin binding to target cells 
[52,53]. Colloid-osmotic mechanisms have been proposed as the principle mechanism 
associated with hemolysis [30,41,54]. This mechanism has been reported in bacteria for δ-
toxin of Bacillus thuringiensis, θ-toxin of Clostridium perfringens and the hemolysins of 
Vibrio vulnificus and Moraxella bovis [55–58]. For fungal hemolysins, both ostreolysin and 
aegerolysin show the typical sigmoidal curve of hemolysis, which is characterized by an 
initial lag phase followed by rapid lysis of target cells [4]. The lag phase is characteristic of 
colloid-osmotic mechanism for lysis and likely represents the time required for monomer 
binding and oligomerization on the surface of target cells followed by the gradual influx of 
ions and water. This leads to swelling and eventually results in the lysis of the target cells.
Secretion of hemolysins
In contrast to bacterial hemolysins that are secreted, the destination of fungal hemolysins 
remains unclear and has not been characterized. Initial studies on the secretion of fungal 
hemolytic factors reported contradicting observations due to the limitations associated with 
extract preparation [22,59–62].
In a study characterizing asp-hemolysin, polyclonal antibodies were generated to a 
recombinant asp-hemolysin and used to demonstrate the hemolysin in the supernatant of A. 
fumigatus cultures [63]. Proteomic analysis of A. fumigatus and A. nidulans demonstrated 
that asp-hemolysin and its homologue (Accession No. CAK37181) are present in fractions 
secreted from growing hyphae [64– 66]. Furthermore, asp-hemolysin was recently reported 
as the 4th most abundant protein in the A. fumigatus secretome [66].
Studies that utilized A. fumigatus glycophosphati-dylinositol (GPI) mutants showed that asp-
hemolysin was absent from the secreted fraction of afpig-a mutants [67]. This suggests a 
possible role for GPI proteins in contributing to secretion of hemolysins, however this 
possibility is currently not well understood.
These findings were recently supported during in vitro studies of A. terreus putative 
hemolysin expression by Nayak and colleagues [3,39], in which the authors produced 
recombinant terrelysin and developed specific monoclonal antibodies that were used to 
quantify the native protein in hyphal and secreted fractions grown in liquid culture at various 
temporal intervals. In these studies, it was observed by ELISA that the highest 
concentrations of terrelysin were found in the culture supernatant during early phases of A. 
terreus hyphal growth [3] when compared to later time points where hyphal growth and 
apical elongation were reduced. It was further observed using immunohistochemistry that 
terrelysin was localized to the apical regions of the hyphae. Since terrelysin lacks a signal 
peptide, it was proposed that terrelysin might either diffuse out or be actively secreted 
during initial hyphal growth (i.e., apical elongation) through other yet uncharacterized 
processes. The rapid diffusion of proteins and enzymes from apical regions of hyphal tips is 
well characterized [68–73].
In contrast to these observations, proteomic studies of A. flavus and A. terreus revealed that 
their homologous hemolysins may not be secreted [74,75]. One of the possible reasons for 
this discrepancy could be that these studies used broad proteomics-based analyses that are 
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less sensitive than monoclonal antibody-based assays. To date, the kinetics of hemolysin 
expression from other filamentous fungal species remains to be characterized.
Hemolysins as virulence factors
Based on a number of mechanistic and characterization studies, several fungal hemolysins 
have been proposed as virulence factors [76,77]. Hemolysins lyse red blood cells resulting in 
the release of iron, an important growth factor for microbes especially during infection [78]. 
The requirement of iron in fungal growth is necessary for metabolic processes and as a 
catalyst for various biochemical processes and has been reviewed in detail elsewhere [79].
Expression of a hemolytic protein with capabilities to lyse red blood cells has also been 
suggested to provide a survival strategy for fungi during opportunistic infections. For 
example, in Candida, the secretion of hemolysin coupled with iron uptake facilitates hyphal 
invasion during disseminated candidiasis [80]. Fungal hemolysins have been reported as a 
potential cause of hemorrhage in several investigations [60,81,82]. Ostreolysin has been 
shown to possess cytolytic and cardiotoxic potential in vitro and in vivo [83– 86]. Similarly, 
non-aegerolysin family hemolysins such as phallolysin, rubescenlysin, flammutoxin and 
others have been identified, purified and extensively characterized for their cytolytic and 
cardiotoxic activities [87– 100]. Most studies on the role of hemolysins in disease have used 
purified or partially purified proteins. For many of these studies, concentrations of the 
proteins used to determine toxic effects have not been studied from a physiologically 
relevant perspective. A recent research article on A. fumigatus that used asp-hemolysin 
mutants showed that the hemolysin concentrations might have been overestimated and may 
not be physiologically relevant during infection [66]. Mutation of asp-hemolysin as well as 
the related asp-hemolysin-like protein did not show any significant reduction in hemolytic 
and cytotoxic activities of the fungus. In this same study, mutants of asp-hemolysin did not 
exhibit any attenuation of virulence by A. fumigatus. Interestingly, a strain with mutations 
for both hemolysins was slightly hypervirulent. These data suggest that the previous 
interpretations of the role of hemolysins in A. fumigatus and other fungal virulence may be 
overestimated. In view of these recent observations, the hemolytic and cytolytic activity 
appears to be only coincidental to a yet uncharacterized intracellular or extracellular 
function.
Role in fungal biology
The likelihood that fungi evolved hemolysins for the sole purpose of lysing red blood cells 
in vivo to improve growth is highly unlikely. Most fungi exist in the environment as 
saprophytes. In some cases, the fungus may grow on or in living tissues especially in an 
immune suppressed individual. This may provide an opportunity for colonization and 
infection. For fungi, animal hosts are a rich source of organic material.
As noted above, recent studies of A. fumigatus, cause one to question whether fungal 
hemolysins have any demonstrable role in pathogenesis [66]. A more likely function for this 
family of proteins would be in the normal physiological processes and raises a valid 
question regarding the role of these proteins in fungal biology.
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Perhaps a clue to understanding hemolysins in relation to fungal biology comes from the 
basidiomycetes where ostreolysin ( Pleurotus ostreatus ) and aegerolysin ( Agrocybe 
aegerita ) are expressed during the initiation of fruiting bodies [4,101]. It is believed that 
these hemolysins have a functional role in hyphal aggregation, although the specific 
mechanisms remain uncharacterized [4,102]. Ostreolysin transcripts have been detected in 
the fruiting bodies of P. ostreatus [4] and the addition of the protein has been reported to 
enhance fruiting initiation in P. ostreatus [103]. These data suggest that the functional role 
of the protein is in the promotion of primordial formation, an early stage in the development 
of the mushroom, especially during hyphal aggregation.
One recent paper does not support this hypothesis [104]. Lakkireddy et al . (2011) recently 
proposed that lectins, aegerolysins and other molecules involved in hyphal aggregation and 
fruiting body formation are not consistently present in members of closely related 
mushrooms. Since primordial formation and hyphal aggregation are fundamental processes 
for growth and development, it is unlikely that a set of proteins with inconsistent distribution 
would play a significant role. The authors acknowledged that hemolysins interact with 
specific receptors (most likely lipid rafts) that may indirectly play a role in hyphal 
aggregation by influencing the frequency of cap formation.
Studies of filamentous fungi have reported a correlation between the kinetics of hemolysin 
expression and fungal growth and development. In studies of the ascomycete species A. 
terreus, detectable quantities of terrelysin are present extracellularly, especially during the 
early stages of germination and hyphal development [3]. Asp-hemolysin transcripts were 
detected from the stages of conidial germination to hyphal extension and branching in A. 
fumigatus; however, deletion of asp-hemolysin in mutant strains of A. fumigatus did not alter 
the phenotype (microscopic and macroscopic) or growth characteristics of the fungus [66]. 
In yeasts, contradicting observations have been reported on expression of hemolysins. In B. 
dermatitidis, the hemolytic activity was highest in the yeast phase of growth, while in C. 
albicans, it was in hyphal stage of growth accompanied with secretion of the hemolysin 
[23,105]. Elsewhere, in C. glabrata, phase switching in the fungus was associated with 
changes in the transcript levels of the hemolysin-coding gene HLP [106]. Investigating the 
role of hemolysins during the early stages of growth, especially in filamentous fungi could 
provide valuable information regarding the functional role of these proteins. It does not 
appear that these proteins are critical for fungal growth but based on these observations, it is 
probable that these proteins have a role in regulating fungal growth. In M. anisopliae, 
upregulation of the hemolysin gene was observed with fungal morphological instability or 
ageing [107]. This suggests a likely function for the product of this gene during 
fragmentation and apoptosis at least in M. anisopliae.
Another interesting aspect related to the role of these proteins in fungal biology is the 
presence of variable numbers of aegerolysin proteins in unrelated fungal taxa (Table 1). A. 
fumigatus possesses two aegerolysin hemolysins that belong to the aegerolysin family of 
proteins, and a third hemolysin that has been identified as an asp-hemolysin-like protein. In 
members of the order Eurotiales, A. niger expresses two proteins that belong to the 
aegerolysin family, while P. chrysogenum possesses sequences for five homologous proteins 
(Table 1). Multiple hemolysins have also been reported in basidiomycetes including P. 
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ostreatus and M. perniciosa [4,108–112]. In M. perniciosa, one hemolysin peaked during 
primordial formation, while another peaked during basidiocarp formation. Expression of a 
homologous protein to pleurotolysin B, peaked in mycelium and primordia, but reduced in 
the basidiocarp. Similarly, studies in A. fumigatus reported that the expression of asp-
hemolysin and the asp-hemolysin-like protein especially in the secreted fractions was 
different at different growth phases [66]. Currently, the biological relevance of having 
multiple hemolysins remains unclear.
Interestingly, a report from the USDA laboratories that examined gene expression in the 
phytopathogen, Alternaria gaisen, reported differential expression of the aegerolysin genes 
in dark and light conditions [113]. Here, significantly higher transcripts were reported from 
fungi exposed to light than those exposed to dark conditions. Future studies are needed to 
characterize the underlying mechanisms that govern expression of these proteins during 
different nutrient, temperature, light, and pH regimens.
Although hemolysins may not be virulence factors, another important function of these 
proteins may be related to their ecological niche. Fungi exist in the environment in 
competition with other fungi, bacteria and insects. Expression of a protein that can lyse a 
competitor ‘ s cells could help provide a survival advantage for the fungal species. In nature, 
especially in basidiomycetes, it has been proposed that hemolysins have a functional role as 
insecticides [114]. Homologous hemolysins derived from several bacterial species including 
Clostridium bifermentans have been reported to have insecticidal properties [35,115,116]. 
To date, insecticidal activity has not been identified for ostreolysin nor has it been reported 
in filamentous fungi. Interestingly, eryngeolysin from P. eryngii exhibited antibacterial 
activity against Bacillus species but not with bacteria from other species [110]. Fungi 
commonly share their local environment with Bacillus species in various phylosphere and 
rhizosphere ecosystems. Secretion of hemolytic proteins that specifically lyse bacteria may 
provide an opportunity to outcompete bacteria for available nutrients and resources.
Research studies have also shown that hemolysins bind to membrane lipids on target cells 
[30,46,84,117– 120]. Ostreolysin has been shown to lyse lipid vesicles generated from 
cholesterol/sphingomyelin and to a lesser extent, ergosterol/sphingomyelin [117]. The 
specificity of binding may provide the fungus with the ability to lyse target cells from plants 
or animals without causing damage to the fungal cell wall. Hemolysin specificity for certain 
lipids must have a relevant biological function. For example, ostreolysin binds to and lyses 
vesicles containing sitosterol, a phytosterol mainly present in plants [117]. Peanuts contain 
large amounts of sitosterol and are very susceptible to infection from fungi, especially 
Aspergillus species [121]. The hemolysins may have a functional role in plant pathogenesis; 
however, this remains largely uncharacterized and is the focus of further study.
Applications of aegerolysins
Enzymes and secondary metabolites of fungi have been utilized in industrial sectors for 
many years. Secondary metabolites from Aspergillus species have been identified as 
hypolipidemic agents and commercially exploited. Lovastatin, a polyketide-derived 
metabolite of A. terreus, was one of the first statins approved by the FDA for lowering 
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cholesterol [122]. Binding of fungal hemolysins to lipids and lipoproteins has been 
extensively studied for asp-hemolysin and ostreolysin [41,123,124]. Asp-hemolysin was 
characterized for its pharmaceutical potential in binding to low-density lipoprotein (LDL) 
and one of its derivatives, oxidized LDL (Ox-LDL) [125,126]. Asp-hemolysin was reported 
to bind specifically to apolipoprotein B in LDL [123,124], and lysophosphatidylcholine in 
Ox-LDL [126–129]. This specific interaction was reported to interfere with the pathological 
role of Ox-LDL in vitro [130– 132]. However, no animal studies have been published that 
show strong evidence for a pharmaceutical relevance of this hemolysin. Interestingly, 
terrelysin was not found to have any binding activity with serum lipids (unpublished data). 
Similarly, ostreolysin and aegerolysin also do not bind LDL [4]. The basis for binding of 
LDL by asp-hemolysin was suggested based on the positioning of certain acidic amino acids 
in the homologous repeats in various loops of the LDL receptor [63]. The critical positioning 
of aspartic acid and glutamic acid is absent for the homologous region in terrelysin and 
ostreolysin and may be a likely explanation for the lack of LDL binding. However, 
interactions with LDL or its derivatives are not only limited to fungal hemolysins and have 
been reported for other aegerolysin family proteins identified in bacteria. PA0122, an 
aegerolysin from P. aeruginosa, has been reported to bind Ox-LDL; however, no 
pharmaceutical potential has been reported [133].
Binding of fungal hemolysins to lipids has been extensively investigated by Sepcic and her 
colleagues at the University of Ljubljana in Slovenia [30,41,46,117,118]. They have 
observed that ostreolysin bound to cholesterol-enriched raft-like microdomains in the cell 
membrane [46,118,134]. Due to the importance of these microdomains in biological 
processes such as conidial germination, hyphal extension, signal transduction and pathogen 
interaction, these hemolysins might be useful tools for characterizing these highly dynamic 
structures in the cell membrane [135– 138].
Mushrooms have been studied extensively for their bio-medical properties. Investigations 
have identified a possible role for fungal hemolysins on contributing to these properties. 
This has generated a considerable interest in understanding the contribution made by 
hemolysins especially as anti-tumor agents [139]. Schizolysin, ( S. commune), eryngeolysin 
( P. eryngii ), nebrodeolysin ( P. nebrodensis) and phallolysin ( A. phalloides ) have been 
shown to possess anti-retroviral activity or cytotoxic to tumor cells; however, more research 
is needed to determine a physiological relevance [110,140–142].
In recent times, considerable interest has grown in use of filamentous fungi and mainly 
Aspergillus species for heterologous protein expression [143,144]. This has been aided by 
genome sequencing of many filamentous fungi and improvements in DNA purification and 
transformation technology. Expression of proteins in fungi is a very attractive avenue since 
they provide an efficient system for secretion of proteins and post-translational 
modifications in an inexpensive manner. Very recently in A. oryzae, the promoter from one 
of its hemolysin-coding genes (Q2TXT6) was identified to possess high promoter activity 
[145]. Genes expressed using this promoter overproduced coded proteins efficiently. More 
importantly, the promoter activity remained high in solid-state fermentations as well as in 
liquid cultures.
Nayak et al. Page 8













Another application of fungal hemolysins has been their use as biomarkers for personal 
exposure to fungi or species-specific identification of opportunistic fungal disease. Much 
interest in the adverse health effects of fungal hemolysins was stimulated by initial 
associations of Stachybotrys chartarum with an outbreak of idiopathic pulmonary 
hemorrhage (IPH) in Cleveland, Ohio, USA [146]. Fungal proteins capable of hemolysis 
were hypothesized as the causative agent and stachylysin was proposed as a potential 
biomarker for exposure to S. chartarum [81,147,148]. Detection of hemolysins from A. 
fumigatus and S. chartarum in sera and tissues of experimentally exposed animals and in 
some humans that worked in heavily contaminated environments further fueled an interest in 
utilizing fungal hemolysins as biomarkers for personal fungal exposure [148– 150]. Recent 
reports on the detection of terrelysin in the culture supernatant of A. terreus [3] and that asp-
hemolysin is the 4th most abundant protein in the secretome of A. fumigatus [66] suggest 
that hemolysins may be promising biomarkers of personal exposure. Collectively, there is 
considerable interest in the development of diagnostic assays for detecting these proteins as 
biomarkers of allergic and disseminated fungal exposure.
Limitations of fungal hemolysin research
Initial studies of hemolytic activity from different fungi used crude extracts or partially 
purified extracts [22,60,61,151– 159]. While these studies were performed with the 
experimental and purification methodologies available at the time, recent studies using 
recombinant proteins to generate specific antibodies have identified limitations in the 
previous work. Recently reported studies on the hemolytic activity of A. terreus, identified 
some critical limitations in purification methodologies [3,39,160]. In these studies, 
hemolytic fractions were purified from A. terreus culture supernatant [160] and found to be 
enriched with the hemolysin based on the functional activity, but on further analysis, the 
preparations were found to consist of at least two proteases. Using proteomic techniques, 
sequences for terrelysin could not be identified. Upon further characterization, the kinetics 
for expression of these proteases and terrelysin were found to be completely different 
[3,160]. As mentioned above, terrelysin was identified as being produced very early in 
culture associated with early hyphal growth. The protocols used for isolating hemolysins 
based on functional activity involved much longer culture times and it is probable that at 
these later time points (stationary growth phase), little hemolysin was produced and 
purification of other proteins such as proteases with hemolytic activity was occurring.
When asp-hemolysin was initially investigated from A. fumigatus, it was reported as a 30 
kDa protein [62]; however, further biochemical characterization by the same group showed 
that asp-hemolysin is a much smaller protein [39,63,161]. This discrepancy was not reported 
when asp-hemolysin was sequenced for the first time or when it was expressed as a 
recombinant protein [63,161]. This raised the question in the early studies on asp-hemolysin 
[62,82,149,162] whether the protein studied was indeed homogenous. This also questions 
the interpretation of studies on the characterization of hemolysins as being important for 
pathogenesis, as later studies clearly provide evidence against their role as virulence factors 
[66]. Future studies on the characterization of hemolytic proteins from fungi need to identify 
the hemolysins by immunochemical or proteomic methods rather than relying on hemolysis 
as a functional assay for purification.
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Using recombinant proteins to characterize the functional activity of hemolysins is not 
without technical concerns. Bacterial aegerolysins in Clostridium bifermentans and 
Pseudomonas aeruginosa were expressed in Escherichia coli as well as Bacillus 
thuringiensis expression systems; however, no hemolytic activity was observed with the 
purified proteins [35,133,163]. It is unclear as to why recombinant hemolysins expressed in 
bacterial expression systems are not functionally active. Several studies have aimed at 
expression of recombinant fungal hemolysins in E. coli also failed to produce functionally 
active hemolysins [39,161,164]. In the case of asp-hemolysin, the protein was expressed as a 
fusion protein with maltose binding protein (MBP) [161]. It is possible that MBP, which is 
almost three times the size of asp-hemolysin, could interfere with the structural 
conformation of the protein and thus affect the hemolytic activity of the protein. For 
flammutoxin, the removal a 20-amino acid region in the C-terminal domain was necessary 
to restore hemolytic activity [164]. In addition, when these proteins are expressed in the 
cytoplasm of the various expression systems, reducing conditions may inhibit the folding of 
the protein to its appropriate functional conformation.
Some studies have reported that these hemolysins possibly consist of multiple components 
and this concept is gaining more credence in recent times [43,111,165]. Previously, two 
component hemolysins have been reported in bacteria [166,167]. It has been suggested that 
two individual components interact with each other and this association is essential for 
hemolysis [165]. Aegerolysin proteins such as asp-hemolysin, ostreolysin, terrelysin, and 
other homologous proteins may interact with a larger subunit to form a functionally active 
two-component hemolysin. Based on sequence information available for the larger subunits, 
we could not identify a homologous protein in A. terreus.
The described limitations highlight the need to re-evaluate the term ‘ hemolysin ‘ as it 
pertains to mycology. A comprehensive review of the literature on fungal hemolysins 
suggests that the definition of hemolysis is vague and requires refinement based on 
characterization of mechanisms underlying hemolysis. Initial studies focused on relatively 
crude or partially purified hemolytic preparations. Functionally, hemolysis was observed but 
these studies were confounded by the presence of other proteins, more specifically 
proteases. As mentioned earlier, at least two proteases were identified that were co-purified 
in these crude preparations [160]. This was further corroborated in a study characterizing A. 
fumigatus strains lacking the protease transcription factor PrtT [168]. PrtT mutant strains 
showed loss of secreted protease activity and demonstrate very low levels of hemolytic 
activity. Fungi are known to secrete phospholipases that interact with host cell membranes 
and result in lysis [77]. In the study of asp-hemolysin mutants with reduced asp-hemolytic 
activity, extracts did not show a significant reduction in the total hemolytic activity of the 
fungus [66]. These studies demonstrate that while asp-hemolysin may contribute to 
hemolysis, specific proteases may be more important to the functional activity that is 
followed in the hemolysin purification protocols.
Finally, non-protein components of fungi with hemolytic activity have also been reported 
[169,170]. Preliminary characterization of hemolysis in Wallemia sebi, a xerotolerant 
basidiomycete, identified unsaturated fatty acids responsible for hemolytic activity, while 
the hemolysin of R. nigricans was characterized as a lipoprotein. These observations suggest 
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that the role of other macro-molecules and secondary metabolites may show hemolysis 
during initial characterization and further highlights issues with extraction and purification.
Summary
Fungal hemolysins belonging to the aegerolysin protein family are characterized by 
pleiotropic functions. These proteins were first identified for their role in pathogenesis as 
virulence factors; however, biochemical characterization studies highlight their function in 
other aspects of fungal biology. The ability of these proteins to bind to unique microdomains 
in the cell membrane opens a new area for research and serves as an essential tool in the 
characterization of the membrane lipids. Additionally, early studies on the detection of 
hemolysins during fungal infections and recent studies on secretion in vitro demonstrate 
their utility as putative biomarkers for fungal exposures. Finally, the wealth of information 
on the function of these proteins in fungal biology suggests a more important role for these 
proteins in fungal growth and regulation. The continued research in this area should provide 
additional insights into these unique proteins and provides an impetus for future research.
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Table 1
List of fungi with identified and described hemolysins
Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
Ascomycetes
Aspergillus clavatus YES A1CGD5 Putative uncharacterized protein
Aspergillus flavus YES B8N206, B8N7M1,
B8NLV7, B8NXA7
Putative uncharacterized proteins
NO N/A • Initial report on hemolysis in A. flavus
• Crude analysis of hemolytic toxins
[22]
[151]
Aspergillus fumigatus YES Q00050 (Strain
FGSCA1100)
Asp-hemolysin
• Initial report on hemolysis in A. 
fumigatus
• No correlation between hemolytic 
activity and toxicity in crude 
preparations
• Hemolytic component can be purified 
only during a limited period
• Initial attempts for purification of the 
hemolysin
• Hemolysin detected in tissues of 
experimental animals
• Toxic effects in animals inject with asp-
hemolysin
• First report of nucleotide sequence of 
asp-hemolysin
• Derivation of hypothesis for interaction 
between asp-hemolysin and LDL
• Asp-hemolysin and LDL and Ox-LDL 
interactions
• Expression of recombinant asp-
hemolysin
• 4th most abundant protein in the 
secretome
• Deletion of the gene did not affect 
hemolytic, cytotoxic and pathological 













• Not detected in the secretome
• Deletion of the gene did not affect 
hemolytic, cytotoxic and pathological 








Aspergillus nidulans YES Q5BD27 Putative uncharacterized protein
Aspergillus niger YES A2QA29 (Strain
FGSCA1513)
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Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
• Detected as a part of the secretome based 








• 72 kDa secreted hemolysin
• Heat labile at 75°C
• α-helical secondary structure
• Toxicity to neuronal cells
[40]
Aspergillus oryzae YES Q2TXT6 HlyA encoded protein
• First report of sequence in the genome 
database of A. oryzae
• Novel promoter for expression of 
heterologous proteins
• Stronger production of expressed 




YES Q2U8×3, Q2UIJ5 Putative uncharacterized proteins
Aspergillus terreus YES Q0CRX8 Terrelysin
• Expression of recombinant terrelysin
• 16.5 kDa β-sheet protein
• Presence of terrelysin during early stages 
of growth
• Detection of terrelysin in culture 
supernatant
• Development of monoclonal antibodies 
for the first aegerolysin family protein
[39]
[3]
Altemaria tenuis NO N/A • First report on hemolytic activity in A. 
tenuis
[152]
Blastomyces dermatitidis YES C5GE86 (Strain ER-3) Putative uncharacterized protein
YES C5JIZ7 (Strain SLH14081) Putative uncharacterized protein
YES F2T7L8 (Strain ATCC
18188)
Putative uncharacterized protein
NO N/A • Identification of hemolytic activity 
associated in the yeast stage
[23]
Candida albicans NO N/A • Hemolysin secretion leads to iron uptake 
which induces phase switching
[80]
NO N/A • Identification of hemolytic activity 
associated in the yeast stage
[23]
NO N/A • Enhanced hemolytic activity in hyphae 
and secretion of hemolysin
[105]
Candida glabrata NO N/A HLP encoded protein [106]
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Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
• Hemolysin gene is involved in the 
phenotype switching
Coccidioides posadasii YES C5P7J6 Putative uncharacterized protein
Cordyceps militaris YES G3JFK8 Putative uncharacterized protein
Cryptococcus
neoformans
NO N/A • Identification of hemolytic activity 
associated in the yeast stage
[23]
Fusarium oxysporum YES F9GD59 Putative uncharacterized protein
Histoplasma capsulatum YES A6R7E8 (Strain WU24) Putative uncharacterized protein
YES C0NGB1 (Strain G18AR) Putative uncharacterized protein
YES C6H8A0 (Strain H143) Putative uncharacterized protein
YES F0U5M1 (Strain H88) Putative uncharacterized protein
NO N/A • Identification of hemolytic activity 
associated in the yeast stage
[23]
Metarhizium acridum YES E9E2I6 Putative uncharacterized protein
Metarhizium anisopliae YES E9EKK1, E9F766 Putative uncharacterized proteins
UNCLEAR N/A • Hemolysin associated with ageing of the 
fungus
[107]
Nectria haematococca YES C7YXA1 Putative uncharacterized protein
Neurospora crassa YES Q1K511 Putative uncharacterized protein
Neurospora tetrasperma YES F8MNX9 (Strain FGSC
2508)
Putative uncharacterized protein





YES C0S9D2 (Strain Pb03) Putative uncharacterized protein
YES C1GBU4 (Strain Pb18) Putative uncharacterized protein
YES C1HAI8 (Strain Pb01) Putative uncharacterized protein





• 2 kDa monomer hemolysin
• Increased production of MIP-2 in murine 
macrophages
[153]
Sordaria macrospora YES F7W167 Putative uncharacterized protein
Stachybotrys chartarum NO N/A Stachylysin
• Initial reports on hemolytic activity in S. 
chartarum ‘ Identification of a 11.9 kDa 
protein
• Heat inactivated
• Slow hemolytic process
• May cause hemorrhaging based on an 
earthworm model
• All strains produce stachylysin in 
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Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
• Stachylysin is localized in inner wall of 
conidia/hyphae
• In tissues from exposed animals 
stachylysin staining was observed 
immediately surrounding the conidia, 
suggesting diffusion from it
• Detection of stachylysin in sera of 
patients and experimental animals
• Stachylysin as a measurable indicator of 
S. chartarum exposure
Trichophyton sp. NO N/A • T. rubrum, T. verrucosum, T. 










• First report of aegerolysins in M. 
perniciosa
• Decreased levels of transcripts in yellow 
and reddish pink mycelium stage and 
prior to stress





• First report of aegerolysins in M. 
perniciosa
• Increased levels of transcripts in the 
basidiomata




YES E2LNF8 Putative uncharacterized protein
• The sequence of this protein is very 
similar to E2LVY5, but is truncated to 
104 amino acids in the database
[112]
NO N/A Deuterolysins
• Identification of sequences similar to 
deuterolysins
[112]
Agrocybe aegerita YES 042717 Aegerolysin
• Cloning and sequencing of aegerolysin 
(Aa-Pril)
• Expressed during fruiting initiation
• Isolation of a 16 kDa hemolytic protein
[102]
[4]
Pleurotus eryngii YES D0FZZ2 Erylysin
• Part of a two-component hemolysin 
system and erylysin A belongs 
aegerolysin family
[111]
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Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
• 15 kDa protein β-sheet protein
UNCLEAR N/A Eryngeolysin
• Not identified as an aegerolysin family 
protein, however, N-terminal sequence 
suggests homology
• Heat labile 17 kDa hemolysin
• Specific cytotoxicity to L1 210 leukemia 
cell line
• Antibacterial activity against Bacillus 
species
[110]
Pleurotus ostreatus YES Q56QW9 Ostreolysin
• First report of cytolytic activity in P. 
ostreatus
• Isolation of ostreolysin, a 16 kDa 
hemolytic protein
• High expression during fruiting initiation 
and primordial formation
• Interactions with membrane lipids
• Mechanism of hemolysis action and 
identification of 4 nm pore size
• Interaction of ostreolysin with 
cholesterol-rich domains in cell 
membranes
• First report on β-sheet secondary 
structure of ostreolysin
• Deviation from optimal pH and 
temperature results in unfolding of 
ostreolysin to α-helical structure
• Unfolding prior to interaction with target 
cells results in loss of hemolytic activity
• Immunolocalization of ostreolysin in 
primordia and fruiting bodies
• Interactions of ostreolysin with lipid 
membranes composed of different 
steroids
• Toxicity of ostreolysin in experimental 
animals
• External addition of ostreolysin enhances 
fruiting initiation













• Part of a two-component hemolysin 
system and pleurotolysin A belongs to 
aegerolysin family
• 17 kDa protein
• The two-component hemolysin 




Pleurotus nebrodensis NO N/A Nebrodeolysin [140]
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Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
• 27 kDa protein
• Cytotoxic to different cell lines
• Induces apoptosis in tumor cells
• Anti-HIV activity
Amanita phalloides NO N/A Phallolysin
• Initial characterization of cytolytic 
activities of phallolysin
• Purification of phallolysin and reporting 
of its cytotoxic activities
• Biochemical characterization of 
phallolysin
• Extensive characterization of hemolysin 
activity
• Electron microscopy-based 
characterization of cytolytic activity
• Mast cell degranulation
• Mechanism of hemolysis by phallolysin
• Phallolysin lyses liposomes containing 
phosphatidylcholine as well as 
sphingomyelin
• Specifically damages liposomes 
containing negatively charged 
phospholipids
• Lectin based hemolytic activity










Amanita rubescens NO N/A Rubescenlysin
• First report on identification of 
rubescenlysin
• Further characterization of hemolytic and 
cytolytic activities
• Mast cell degranulation
• Toxic effects in experimental animals
• Intravascular hemolysis and alveolar 
obstruction, hemorrhagic pulmonary 
edema in experimental animals







Hypholoma fasciculare NO N/A Fascicularelysin
• Mast cell degranulation
[92]
Laetiporus sulphureus NO N/A LSL
• Lectin-based hemolytic activity
• 35 kDa protein
• N-terminal domain recognizes 
carbohydrates
• C-terminal domain is responsible for 
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Fungal division/Fungi Aegerolysin
Accession number
(UniProtKB) Important notes Reference
• Structural similarity to MTX2 (B. 
sphaericus) and a toxin (C. septicum)
• N-terminal domain structure has a β-
trefoil scaffold similar to that of ricin
• C-terminal domain structure is similar to 
that aerolysin (Aeromonas hydrophila)
Rhodophyllus
rhodopolius
NO N/A • Purification of hemolysin from R. 
rhodopolius
• 40 kDa heat labile hemolysin
[157]
Flammulina velutipes NO N/A Flammutoxin
• Isolation of flammutoxin and 
identification of cardiotoxicity
• Characterization of cardiotoxicity of 
flammutoxin
• Characterization of hemolytic activity of 
flammutoxin
• Purification of a 31 kDa protein and 
aggregates to form a 180 kDa protein on 
erythrocytes
• Electrophysiological properties of 
flammutoxin and identification of two 
different forms of pores on target cells








Volvariella volvacea NO N/A • Cardiotoxic hemolytic protein [100]
Termitomyces clypeatus NO N/A • Purification of ~64 kDa hemolysin
• Suggestion of interactions with 
phospholipids
[120]
Schizophyllum commune NO N/A Schizolysin
• 29 kDa hemolysin isolated from fruiting 
bodies
• Heat labile above 60°C
• Inhibits HIV-1 reverse transcriptase 
activity
[142]





NO N/A • Initial characterization of hemolytic 
activity in R. nigricans
• Heat stable hemolysin and resistant to 
proteolytic activity
• Hemolysin may be a lipoprotein
[159]
[170]
Rhizopus arrhizus NO N/A • Initial characterization of hemolytic 
activity in R. arrhizus
[159]
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